Loren J. Martin

Dr. Loren J. Martin

orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 June 2015 in Nature Neuroscience
Verified
Journal Article
Closed access
PDF file
RSRobert E Sorge
Robert E Sorge
JMJosiane C S Mapplebeck
Josiane C S Mapplebeck
SRSarah Rosen
Sarah Rosen
SBSimon Beggs
Simon Beggs
STSarah Taves
Sarah Taves
JMJeffrey S Mogil
Jeffrey S Mogil

28 April 2014 in Nature Methods
Verified
Journal Article
Closed access
RSRobert E Sorge
Robert E Sorge
LMLoren J. Martin
Loren J. Martin
KIKelsey A Isbester
Kelsey A Isbester
SSSusana G Sotocinal
Susana G Sotocinal
SRSarah Rosen
Sarah Rosen
JMJeffrey S Mogil
Jeffrey S Mogil

1 January 2011 in Molecular Pain
Verified
Journal Article
Open access
PDF file
SSSusana G Sotocinal
Susana G Sotocinal
RSRobert E Sorge
Robert E Sorge
AZAustin Zaloum
Austin Zaloum
ATAlexander H Tuttle
Alexander H Tuttle
LMLoren J. Martin
Loren J. Martin
JMJeffrey S Mogil
Jeffrey S Mogil
We recently demonstrated the utility of quantifying spontaneous pain in mice via the blinded coding of facial expressions. As the majority of preclinical pain research is in fact performed in the laboratory rat, we attempted to modify the scale for use in this species. We present herein the Rat Grimace Scale, and show its reliability, accuracy, and ability to quantify the time course of spontaneous pain in the intraplantar complete Freund's adjuvant, intraarticular kaolin-carrageenan, and laparotomy (post-operative pain) assays. The scale's ability to demonstrate the dose-dependent analgesic efficacy of morphine is also shown. In addition, we have developed software, Rodent Face Finder®, which successfully automates the most labor-intensive step in the process. Given the known mechanistic dissociations between spontaneous and evoked pain, and the primacy of the former as a clinical problem, we believe that widespread adoption of spontaneous pain measures such as the Rat Grimace Scale might lead to more successful translation of basic science findings into clinical application.

6 September 2009 in Nature Neuroscience
Verified
Journal Article
Closed access
PDF file
HSHong-Shuo Sun
Hong-Shuo Sun
MJMichael F Jackson
Michael F Jackson
LMLoren J. Martin
Loren J. Martin
KJKaren Jansen
Karen Jansen
LTLucy Teves
Lucy Teves
MTMichael Tymianski
Michael Tymianski

1 February 2015 in Current Biology
Verified
Journal Article
Closed access
LMLoren J. Martin
Loren J. Martin
GHGeorgia Hathaway
Georgia Hathaway
KIKelsey Isbester
Kelsey Isbester
SMSara Mirali
Sara Mirali
EAErinn L. Acland
Erinn L. Acland
JMJeffrey S. Mogil
Jeffrey S. Mogil

5 April 2006 in The Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
VCVictor Y. Cheng
Victor Y. Cheng
LMLoren J. Martin
Loren J. Martin
EEErin M. Elliott
Erin M. Elliott
JKJohn H. Kim
John H. Kim
HMHoward T. J. Mount
Howard T. J. Mount
BOBeverley A. Orser
Beverley A. Orser
A fundamental objective of anesthesia research is to identify the receptors and brain regions that mediate the various behavioral components of the anesthetic state, including amnesia, immobility, and unconsciousness. Using complementaryin vivoandin vitroapproaches, we found that GABAAreceptors that contain the α5 subunit (α5GABAARs) play a critical role in amnesia caused by the prototypic intravenous anesthetic etomidate. Whole-cell recordings from hippocampal pyramidal neurons showed that etomidate markedly increased a tonic inhibitory conductance generated by α5GABAARs, whereas synaptic transmission was only slightly enhanced. Long-term potentiation (LTP) of field EPSPs recorded in CA1 stratum radiatum was reduced by etomidate in wild-type (WT) but not α5 null mutant (α5−/−) mice. In addition, etomidate impaired memory performance of WT but not α5−/− mice for spatial and nonspatial hippocampal-dependent learning tasks. The brain concentration of etomidate associated with memory impairmentin vivowas comparable with that which increased the tonic inhibitory conductance and blocked LTPin vitro. The α5−/− mice did not exhibit a generalized resistance to etomidate, in that the sedative-hypnotic effects measured with the rotarod, loss of righting reflex, and spontaneous motor activity were similar in WT and α5−/− mice. Deletion of the α5 subunit of the GABAARs reduced the amnestic but not the sedative-hypnotic properties of etomidate. Thus, the amnestic and sedative-hypnotic properties of etomidate can be dissociated on the basis of GABAAR subtype pharmacology.